LEVEL 4 G04BD09

Δραστικές

Φάρμακα

  • DRUGBANK - Trospium
  • indication:

    For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, detrusor instability and frequency of micturition.

  • pharmacology:

  • mechanism:

    Trospium antagonizes the effect of acetylcholine on muscarinic receptors in cholinergically innervated organs. Its parasympatholytic action reduces the tonus of smooth muscle in the bladder.

  • toxicity:

  • absorprion:

    9.6%

  • halflife:

    20 hours

  • roouteelimination:

    After administration of oral 14C-trospium chloride, the majority of the dose (85.2%) was recovered in feces and a smaller amount (5.8% of the dose) was recovered in urine; 60% of the radioactivity excreted in urine was unchanged trospium. The mean renal clearance for trospium (29.07 L/hour) is 4-fold higher than average glomerular filtration rate, indicating that active tubular secretion is a major route of elimination for trospium. SANCTURA ® is metabolized by ester hydrolysis and excreted by the kidneys by a combination of tubular secretion and glomerular filtration.

  • volumedistribution:

    * 395 ± 140 L

  • clearance:

    * Renal cl=29.07 L/hour